CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 55 filers reported holding CORVUS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $4,782,399 | 1.67% |
| TOWERVIEW LLC | 342,478 | $500,018 | 0.33% |
| Orbimed Advisors | 6,943,654 | $10,137,735 | 0.22% |
| SAMLYN CAPITAL, LLC | 2,405,764 | $3,512,415 | 0.06% |
| BVF INC/IL | 1,370,947 | $2,001,583 | 0.05% |
| JACKSON SQUARE CAPITAL, LLC | 63,773 | $93,109 | 0.04% |
| MYDA Advisors LLC | 68,814 | $100,468 | 0.03% |
| Masso Torrence Wealth Management Inc. | 10,000 | $14,600 | 0.01% |
| Hikari Power Ltd | 49,959 | $73 | 0.01% |
| XTX Topco Ltd | 19,244 | $28,096 | 0.01% |